UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement

British journal of clinical pharmacology, 2021-12, Vol.87 (12), p.4658-4669

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects

British journal of clinical pharmacology, 2018-10, Vol.84 (10), p.2422-2432

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Bioavailability of Aerosolized Tobramycin in Cystic Fibrosis

Chest, 2002-07, Vol.122 (1), p.219-226

2002

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial

Lancet neurology, 2024-05, Vol.23 (5), p.477-486

2024

Link zum Volltext

Verfügbarkeit prüfen

pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment

Cancer chemotherapy and pharmacology, 2010-07, Vol.66 (2), p.345-356

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical pharmacokinetics of thalidomide

Clinical pharmacokinetics, 2004-01, Vol.43 (5), p.311-327

2004

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma

Journal of experimental & clinical cancer research, 2013-10, Vol.32 (1), p.74-74, Article 74

2013

Link zum Volltext

Verfügbarkeit prüfen

Thalidomide Dose Proportionality Assessment following Single Doses to Healthy Subjects

Journal of clinical pharmacology, 2001-06, Vol.41 (6), p.662-667

2001

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and pharmacodynamics of hydroxyurea

Clinical pharmacokinetics, 1998-05, Vol.34 (5), p.347-358

1998

Link zum Volltext

Verfügbarkeit prüfen

Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women

Biopharmaceutics & drug disposition, 2000-01, Vol.21 (1), p.33-40

2000

Link zum Volltext

Verfügbarkeit prüfen

The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans

Clinical pharmacokinetics, 1991-06, Vol.20 (6), p.477-490

1991

Link zum Volltext

Verfügbarkeit prüfen

Effect of colesevelam on lovastatin pharmacokinetics

The Annals of pharmacotherapy, 2002-03, Vol.36 (3), p.392

2002

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetics of hydroxyurea in cancer patients

Cancer chemotherapy and pharmacology, 1995-01, Vol.35 (5), p.417-422

1995

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of Glyburide in Patients with Well-Controlled Diabetes

Pharmacotherapy, 1998-01, Vol.18 (1), p.51-56

1998

Link zum Volltext

Verfügbarkeit prüfen

Thalidomide Dose Proportionality Assessment following Single Doses to Healthy Subjects

Journal of clinical pharmacology, 2001-06, Vol.41 (6), p.662-667

2001

Link zum Volltext

Verfügbarkeit prüfen

Nonlinear disposition of hydroxyurea

Journal of pharmaceutical sciences, 1994-07, Vol.83 (7), p.1060-1061

1994

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of an antisense phosphorothioate oligodeoxynucleotide against rev from human immunodeficiency virus type 1 in the adult male rat following single injections and continuous infusion

Antisense research and development, 1994, Vol.4 (1), p.43-52

1994

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and in vivo effects of a six-base phosphorothioate oligodeoxynucleotide with anticancer and hematopoietic activities in swine

Journal of hematotherapy & stem cell research, 2000-04, Vol.9 (2), p.205-214

2000

Link zum Volltext

Verfügbarkeit prüfen

Absolute and Relative Bioavailability of Fentanyl Buccal Tablet and Oral Transmucosal Fentanyl Citrate

Journal of clinical pharmacology, 2007-03, Vol.47 (3), p.343-350

2007

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic properties of fentanyl effervescent buccal tablets: A phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 μg in healthy adult volunteers

Clinical therapeutics, 2006-05, Vol.28 (5), p.707-714

2006

Link zum Volltext

Verfügbarkeit prüfen

Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot study

Clinical drug investigation, 2007-01, Vol.27 (9), p.605-611

2007

Link zum Volltext

Verfügbarkeit prüfen

Bioequivalence Following Buccal and Sublingual Placement of Fentanyl Buccal Tablet 400 μg in Healthy Subjects

Clinical drug investigation, 2008, Vol.28 (1), p.1-7

2008

Link zum Volltext

Verfügbarkeit prüfen

Bioequivalence Following Buccal and??Sublingual Placement of Fentanyl??Buccal Tablet 400????g in??Healthy Subjects

Clinical drug investigation, 2008-01, Vol.28 (1), p.1-7

2008

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers

Clinical therapeutics, 2006-05, Vol.28 (5), p.707-714

2006

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic properties of fentanyl effervescent buccal tablets: A phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 [mu]g in healthy adult volunteers

Clinical therapeutics, 2006-05, Vol.28 (5), p.707

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement

Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects

Pharmacokinetics and Bioavailability of Aerosolized Tobramycin in Cystic Fibrosis

Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial

pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment

Clinical pharmacokinetics of thalidomide

Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma

Thalidomide Dose Proportionality Assessment following Single Doses to Healthy Subjects

Pharmacokinetics and pharmacodynamics of hydroxyurea

Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women

The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans

Effect of colesevelam on lovastatin pharmacokinetics

Population pharmacokinetics of hydroxyurea in cancer patients

Population Pharmacokinetics of Glyburide in Patients with Well-Controlled Diabetes

Thalidomide Dose Proportionality Assessment following Single Doses to Healthy Subjects

Nonlinear disposition of hydroxyurea

Pharmacokinetics of an antisense phosphorothioate oligodeoxynucleotide against rev from human immunodeficiency virus type 1 in the adult male rat following single injections and continuous infusion

Pharmacokinetics and in vivo effects of a six-base phosphorothioate oligodeoxynucleotide with anticancer and hematopoietic activities in swine

Absolute and Relative Bioavailability of Fentanyl Buccal Tablet and Oral Transmucosal Fentanyl Citrate

Pharmacokinetic properties of fentanyl effervescent buccal tablets: A phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 μg in healthy adult volunteers

Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot study

Bioequivalence Following Buccal and Sublingual Placement of Fentanyl Buccal Tablet 400 μg in Healthy Subjects

Bioequivalence Following Buccal and??Sublingual Placement of Fentanyl??Buccal Tablet 400????g in??Healthy Subjects

Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers

Pharmacokinetic properties of fentanyl effervescent buccal tablets: A phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 [mu]g in healthy adult volunteers

Suchergebnisse filtern